Search results

Our Medical Technologies Evaluation Programme (MTEP) evaluates new HealthTech.

We want you to be involved in our work - whether you’re commenting on our draft recommendations, taking part in guidance development or attending a committee meeting, your voice is important to us.

Clarification on demonstrating patient access to medicines and treatments recommended by NICE Technology Appraisal (TA) or Highly Specialised Technologies (HST) guidance.

NICE has a key role in UK licensing and the evaluation of and access to new and innovative products for the health system.

Home What NICE does Our guidance About technology appraisal guidance {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":

Data on the cancer recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.

Our modular updates framework ensures flexibility and consistency in updating our manuals and helps prioritise important updates.

Data on the recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.

NICE priority methodological research areas.

Home What NICE does Our guidance About technology appraisal guidance Our methods and processes (health technology evaluation manual)...

NICE Listens is our programme of deliberative public engagement. It's used to give us an understanding of public opinion on moral, ethical and social value issues.

All the templates and supporting documents you need to make a technology appraisals submission with NICE.

Home What NICE does Our research work {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1

Engage at the optimal time for your technology appraisal, to achieve NICE guidance at the same time as marketing authorisation.

Each year we work with NHSE and the DHSC to prioritise topics for development.